UK markets close in 43 minutes

Bicycle Therapeutics plc (BCYC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
23.19+0.30 (+1.31%)
As of 10:46AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-168,163
-180,664
-112,717
-66,819
-51,010
Depreciation & amortisation
6,647
6,546
3,689
1,409
1,277
Deferred income taxes
4,645
3,306
-4,976
-1,668
-673
Stock-based compensation
32,717
32,477
26,779
12,083
6,514
Change in working capital
38,022
76,663
672
39,733
26,025
Accounts receivable
-37
2,482
-1,641
4,543
-2,149
Accounts payable
4,080
8,002
2,561
1,196
-663
Other working capital
-85,928
-63,557
-105,098
-16,824
-18,989
Other non-cash items
1,046
1,044
442
468
78
Net cash provided by operating activities
-85,086
-60,628
-86,111
-14,794
-17,789
Cash flows from investing activities
Investments in property, plant and equipment
-842
-2,929
-18,987
-2,030
-1,200
Net cash used for investing activities
-842
-2,929
-18,987
-2,030
-1,200
Cash flows from financing activities
Common stock issued
246,629
249,345
5,703
298,542
48,144
Other financing activities
-
-
-
-
-573
Net cash used provided by (used for) financing activities
249,180
250,027
6,692
320,725
62,843
Net change in cash
163,729
187,816
-99,526
302,690
43,873
Cash at beginning of period
293,815
339,154
438,680
135,990
92,117
Cash at end of period
457,067
526,970
339,154
438,680
135,990
Free cash flow
Operating cash flow
-85,086
-60,628
-86,111
-14,794
-17,789
Capital expenditure
-842
-2,929
-18,987
-2,030
-1,200
Free cash flow
-85,928
-63,557
-105,098
-16,824
-18,989